Regeneron Pharmaceuticals
REGN
REGN
638 hedge funds and large institutions have $26.9B invested in Regeneron Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 239 increasing their positions, 200 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.59% less ownership
Funds ownership: 69.35% → 67.76% (-1.6%)
17% less capital invested
Capital invested by funds: $32.3B → $26.9B (-$5.46B)
31% less funds holding in top 10
Funds holding in top 10: 16 → 11 (-5)
Holders
638
Holding in Top 10
11
Calls
$1.23B
Puts
$1.26B
Top Buyers
| 1 | +$197M | |
| 2 | +$195M | |
| 3 | +$181M | |
| 4 |
Two Sigma Advisers
New York
|
+$154M |
| 5 |
Two Sigma Investments
New York
|
+$139M |
Top Sellers
| 1 | -$713M | |
| 2 | -$552M | |
| 3 | -$455M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$269M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$211M |